L-Carnitine ameliorates glycerol-induced myoglobinuric acute renal failure in rats. 2009

Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
Trakya University Faculty of Medicine, Department of Nephrology, Edirne, Turkey. sedatustundag@yahoo.com

There is increasing evidence indicating that oxidative stress plays an important role in the pathogenesis of rhabdomyolysis-induced myoglobinuric acute renal failure (ARF). During times of war and natural disasters, myoglobinuric ARF can assume epidemic proportions. Thus, early and effective renoprotective treatments are of utmost importance. It has been shown that L-carnitine, used as a safe and effective nutritional supplement for more than three decades, is effective in preventing renal injury in many renal injury models involving oxidative stress. The present study was performed to investigate the effects of L-carnitine in an experimental model of myoglobinuric ARF. Four groups of rats were employed in this study: group 1 served as a control; group 2 was given glycerol (10 mL/kg, i.m.); group 3 was given glycerol plus L-carnitine (100 mg/kg, i.p.), starting at the same time as the glycerol injection; group 4 was given glycerol plus L-carnitine (100 mg/kg, i.p.), starting 48h before the glycerol injection. After glycerol injections, the i.p. injections of L-carnitine were repeated every 24h for four days. Ninety-six hours after glycerol injections, blood samples and kidney tissues were taken from the anesthetized rats. Urea and creatinine levels in plasma, N-acetyl-beta-D-glucosaminidase activity in urine, and malondialdehyde levels and catalase enzyme activity in kidney tissue were determined. Histopathological changes and iron accumulation in the kidney tissue were evaluated. In this study, glycerol administration led to marked renal oxidative stress, as well as severe functional and morphological renal deterioration. L-carnitine, possibly via its antioxidant properties, ameliorates glycerol-induced myoglobinuric kidney injury.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009212 Myoglobinuria The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis. Myoglobinurias
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014803 Vitamin B Complex A group of water-soluble vitamins, some of which are COENZYMES. B Vitamin,B Vitamins,Neurobion,Vitamin, B
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
January 2006, Clinical and experimental pharmacology & physiology,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
June 1983, Canadian journal of physiology and pharmacology,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
April 2012, Journal of molecular histology,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
December 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
January 2013, Renal failure,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
August 1988, Japanese journal of medicine,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
July 2009, Basic & clinical pharmacology & toxicology,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
May 2004, Journal of cardiovascular pharmacology,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
August 1996, The American journal of the medical sciences,
Sedat Ustundag, and Saniye Sen, and Omer Yalcin, and Senturk Ciftci, and Bora Demirkan, and Mevlut Ture
January 1993, Journal of basic and clinical physiology and pharmacology,
Copied contents to your clipboard!